Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Cochlear Limited (COH) Will Pay A $1.60 Dividend

Cochlear Limited (ASX:COH) reported a 9% increase in revenue for its 2018 financial year on Tuesday. Cochlear will pay a final dividend of $1.60 per share. 

Global hearing aids business Cochlear Limited (ASX: COH) reported a 9% increase in revenue for its 2018 financial year on Tuesday and revealed it will pay a final dividend of $1.60 per share.

Cochlear is the world’s leading maker of hearing aids and associated accessories.

For the 12 month period to June 30th, 2018, Cochlear reported:

  • Revenue of $1.35 billion, up 9%
  • Profit of $245 million, up 10%
  • A final fully franked dividend of $1.60 per share, up from $1.40

Together with an interim dividend of $1.40 Cochlear will have paid total dividends of $3.00 for its 2018 financial year.

Analysts surveyed by Bloomberg had forecast Cochlear to make a profit of $246 million and pay full-year dividends of $3.06. Therefore, it seems Cochlear’s performance was broadly in-line with analyst expectations.

“The growth we have experienced over the past few years has continued in FY18,” CEO Dig Howitt said.

“The business delivered strong growth in cochlear implant units and sales revenue, with net profit growing by 10%.”

Howitt said Cochlear sold its 500,000th hearing implant during the year, reaching 550,000 units by year-end, but said there is still plenty for the company to do.

“While a wonderful milestone for the Company, it is also a reminder of the challenge, and opportunity, for Cochlear with fewer than 5% of the people who could benefit from an implantable hearing solution currently being treated.”

Cochlear set its 2019 net profit guidance between $265 million and $275 million, signalling growth of more than 8% in the year ahead.

“Over the next few years, we have a number of large long-term investment projects including the development of our China manufacturing facility, with the construction phase expected to be complete by the end of FY20, and investments in IT platforms to strengthen our connected health, digital and cyber security capabilities,” Howitt concluded.

Over the past year Cochlear shares have risen from a low of around $142 to almost $200, according to Google Finance.

Introducing The Australian Investors Podcast

Join The Rask Group’s founder, Owen Raszkiewicz, as he profiles Australia’s best investors, founders, authors and financial thinkers. Download it free on iTunesCastboxSoundCloud or wherever you choose to listen.

itunessoundcloudcastboxdownload

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Skip to content